Insulin aspart, recombinant Subcutaneous and Tinzaparin Subcutaneous
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Tinzaparin Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: tinzaparin
Brand name:
Synonyms: Tinzaparin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Tiotropium
- Insulin aspart, recombinant Subcutaneous-Tiotropium and Olodaterol
- Insulin aspart, recombinant Subcutaneous-Tiotropium and olodaterol Inhalation
- Insulin aspart, recombinant Subcutaneous-Tiotropium Bromide
- Insulin aspart, recombinant Subcutaneous-Tiotropium Capsules for Inhalation
- Insulin aspart, recombinant Subcutaneous-Tiotropium inhalation
- Tinzaparin Subcutaneous-Insulin degludec
- Tinzaparin Subcutaneous-Insulin Degludec (U-100) Prefilled Pens
- Tinzaparin Subcutaneous-Insulin Degludec (U-100) Vials
- Tinzaparin Subcutaneous-Insulin Degludec (U-200) Prefilled Pens
- Tinzaparin Subcutaneous-Insulin degludec and liraglutide
- Tinzaparin Subcutaneous-Insulin degludec and liraglutide Subcutaneous